Safety and utility of ultrasound-guided superior cervical ganglion block for headaches and orofacial pain: a retrospective, single-center study of 10 patients.
Headache
Orofacial pain
Stellate ganglion blocks
Superior cervical ganglion block
Ultrasound guidance
Journal
JA clinical reports
ISSN: 2363-9024
Titre abrégé: JA Clin Rep
Pays: Germany
ID NLM: 101682121
Informations de publication
Date de publication:
29 Apr 2023
29 Apr 2023
Historique:
received:
07
01
2023
accepted:
21
04
2023
revised:
17
04
2023
medline:
29
4
2023
pubmed:
29
4
2023
entrez:
29
4
2023
Statut:
epublish
Résumé
Several new ultrasound-guided superior cervical ganglia blocks (U-SCGBs) have been proposed to overcome the shortcomings of conventional superior cervical ganglia blocks; however, their clinical utility and practicality have not yet been demonstrated. The aim of this study was to evaluate the safety and utility of a new method of U-SCGB. We retrospectively collected data on patients who underwent U-SCGB for the treatment of headaches and orofacial pain at a single center. U-SCGB was performed by injecting 2-3 mL of 1% mepivacaine posterior to the internal carotid artery, just above the bifurcation. The Wilcoxon signed-rank test was used to compare pain scores. Numerical data are expressed as the mean ± standard error. The total number of U-SCGB procedures was 43. All procedures were accompanied by Horner's sign. The numerical rating scale score for pain (possible scores, 0-10) was reduced predominantly from 7.0 ± 0.7 before treatment to 4.5 ± 0.7 at the follow-up (p = 0.014). U-SCGB was considered a clinically useful and accurate treatment for headaches and orofacial pain in this study.
Sections du résumé
BACKGROUND
BACKGROUND
Several new ultrasound-guided superior cervical ganglia blocks (U-SCGBs) have been proposed to overcome the shortcomings of conventional superior cervical ganglia blocks; however, their clinical utility and practicality have not yet been demonstrated. The aim of this study was to evaluate the safety and utility of a new method of U-SCGB.
METHODS
METHODS
We retrospectively collected data on patients who underwent U-SCGB for the treatment of headaches and orofacial pain at a single center. U-SCGB was performed by injecting 2-3 mL of 1% mepivacaine posterior to the internal carotid artery, just above the bifurcation. The Wilcoxon signed-rank test was used to compare pain scores. Numerical data are expressed as the mean ± standard error.
RESULTS
RESULTS
The total number of U-SCGB procedures was 43. All procedures were accompanied by Horner's sign. The numerical rating scale score for pain (possible scores, 0-10) was reduced predominantly from 7.0 ± 0.7 before treatment to 4.5 ± 0.7 at the follow-up (p = 0.014).
CONCLUSION
CONCLUSIONS
U-SCGB was considered a clinically useful and accurate treatment for headaches and orofacial pain in this study.
Identifiants
pubmed: 37119368
doi: 10.1186/s40981-023-00613-z
pii: 10.1186/s40981-023-00613-z
pmc: PMC10148940
doi:
Types de publication
Journal Article
Langues
eng
Pagination
21Informations de copyright
© 2023. The Author(s).
Références
Case Rep Med. 2018 May 24;2018:5247594
pubmed: 29977303
Reg Anesth Pain Med. 2006 Sep-Oct;31(5):460-2
pubmed: 16952820
Schmerz. 2006 Aug;20(4):268-72, 274-6
pubmed: 16432740
Pain Physician. 2000 Jul;3(3):294-304
pubmed: 16906187
Reg Anesth Pain Med. 2017 Nov/Dec;42(6):778-781
pubmed: 28902009
Reg Anesth Pain Med. 2019 Apr 16;:
pubmed: 30992414
Cephalalgia. 2018 Jan;38(1):1-211
pubmed: 29368949
Curr Pain Headache Rep. 2014 Jun;18(6):424
pubmed: 24760493
Circ J. 2009 Oct;73(10):1909-13
pubmed: 19713654
Anesth Analg. 2012 Feb;114(2):462-5
pubmed: 22104074
Brain Behav. 2016 Dec 29;7(2):e00619
pubmed: 28239529
Pain Med. 2013 May;14(5):646-9
pubmed: 23438374
Headache. 2021 Oct;61(9):1441-1451
pubmed: 34618363
Stroke. 2003 Apr;34(4):961-7
pubmed: 12649526
Br J Anaesth. 2013 Jul;111(1):95-104
pubmed: 23794651
Anesthesiology. 2006 Dec;105(6):1238-45; discussion 5A-6A
pubmed: 17122587